BiotechTube
Discover
News
Company
Sign in
BiotechTube
Home
/
Nano Pharmasolutions
/
Justin Cho
JC
Justin Cho
Chief Business Officer
Nano Pharmasolutions
Therapeutic Areas
Central Nervous System (CNS)
Neurology
Nano Pharmasolutions Pipeline
Drug
Indication
Phase
NT-301
Neurological Disorder (Likely Parkinson's Disease)
Phase 1
NT-401
CNS Disorder
Preclinical
NT-501
CNS Disorder
Preclinical
Leadership Team at Nano Pharmasolutions
KO
Kay Olmstead
CEO, Chief Executive Officer
WM
William Martin
COO, Chief Operations Officer
SS
S. Shrewsbury
Chief Medical Officer
SK
Sam Koh
CTO, Chief Technology Officer
View full Nano Pharmasolutions profile